Bioequivalence of saxagliptin/dapagliflozin fixed‐dose combination tablets compared with coadministration of the individual tablets to healthy subjects

Saxagliptin and dapagliflozin are individually indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The bioequivalence of saxagliptin/dapagliflozin 2.5/5 mg and 5/10 mg fixed‐dose combination (FDC) tablets compared with coadministration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vakkalagadda, Blisse, Vetter, Marion L., Rana, Jignasa, Smith, Charles H., Huang, Jian, Karkas, Jennifer, Boulton, David W., LaCreta, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777251/
https://www.ncbi.nlm.nih.gov/pubmed/27022473
http://dx.doi.org/10.1002/prp2.201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777251/
https://www.ncbi.nlm.nih.gov/pubmed/27022473
http://dx.doi.org/10.1002/prp2.201

Ejemplares similares